pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,787 catalysts · 4,779 phase readout · 2,339 8k filing · 285 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: filing×type: approval×type: phase readout×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings285
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Ophthalmology5

    Date TBD

    50
    ›COMPLETEDphase readoutNCT04291859: Lu AF28996 in Participants With Parkinson's Disease (PD)

    Sponsor: H. Lundbeck A/S. Phase: PHASE1. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06951880: A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07483827: A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy

    Sponsor: eleva GmbH. Phase: PHASE1. Conditions: C3 Glomerulopathy (C3G), Healthy Adult Participants

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06888427: Sleep Longitudinal Exploration of the Experience of Patients

    Sponsor: Centre Hospitalier Universitaire de Nice. Phase: . Conditions: Sleep

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04641442: Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02642042: Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: KRAS Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07370870: Is Cryotherapy Beneficial After Surgical Removal of Impacted Lower Third Molars?

    Sponsor: Henrique Tedesco. Phase: NA. Conditions: Cold Therapy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03265262: The Basophil Activation Test as a Diagnostic Tool in Pediatric Food Allergy

    Sponsor: Assistance Publique Hopitaux De Marseille. Phase: NA. Conditions: FOOD ALLERGY

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06572046: STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies

    Sponsor: IRCCS Fondazione Stella Maris. Phase: . Conditions: Hereditary Spastic Paraplegia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07368946: Phosphate Assessment in Chronic Kidney Disease Patients Study

    Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease Mineral and Bone Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07343427: Impact of GON PRF on Central Sensitization in Migraine Patients

    Sponsor: Ankara City Hospital Bilkent. Phase: NA. Conditions: Migraine, Central Sensitization

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06150027: Efficacy of a Systematic Referral to Palliative Care of Patients Who Need for Palliative Care During an Unscheduled Visit in Comprehensive Anticancer Centers

    Sponsor: Centre Leon Berard. Phase: NA. Conditions: Cancer, Emergencies

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05043870: Combined Immunosuppression for Pediatric Crohn's Disease

    Sponsor: Children's Hospital of Fudan University. Phase: PHASE4. Conditions: Crohn Disease, Infliximab, Immunosuppression, Children, Only

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07573670: A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia

    Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Newly Diagnosed Mixed Phenotype Acute Leukemia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07607470: Large Algorithm Setting and Validation Study

    Sponsor: Nanopath, Inc. Phase: . Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, Vaginitis, Vaginal Diseases, Genital Diseases, Female, Female Urogenital Diseases, Urogenital Disease, Candidiasis, Mycoses, Vulvovaginitis, Vulvar Diseases, Vaginosis, Bacterial

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07030673: Early Discontinuation of Antibiotic Therapy in Elderly Patients Hospitalized for a Viral Infection

    Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Elderly, Antibiotics Overuse, Viral Infections, PCR Multiplex

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04232969: Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease

    Sponsor: University College, London. Phase: PHASE3. Conditions: Parkinson's Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06748469: Efficacy of Pulse Radiofrequency Durations in Lumbosacral Pain

    Sponsor: Ankara City Hospital Bilkent. Phase: . Conditions: RADICULAR PAIN

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07367269: Effect of Mandala Coloring on Anxiety, Distress, and Comfort in Breast Cancer Patients Receiving Outpatient Chemotherapy

    Sponsor: Artvin Coruh University. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07209683: The Effect of Near-infrared Light Therapy on Brain Function and Cognition in Young and Older Adults

    Sponsor: University of Oklahoma. Phase: NA. Conditions: Cognition, Neurovascular Coupling Mechanism and Cognitive Function, Neurovascular Control, Brain Aging, Brain Activity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07578454: VRehab-SMA Phase 1.2

    Sponsor: University of Oxford. Phase: NA. Conditions: Spinal Muscular Atrophy (SMA)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05338905: Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial

    Sponsor: Roswell Park Cancer Institute. Phase: NA. Conditions: Head and Neck Squamous Cell Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02313194: Spinal Cord Neuromodulation for Spinal Cord Injury

    Sponsor: University of California, Los Angeles. Phase: PHASE1. Conditions: Cervical Spinal Cord Injury, Tetraparesis, Tetraplegia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07323056: Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung Cancer

    Sponsor: Shanghai Pulmonary Hospital, Shanghai, China. Phase: PHASE2. Conditions: EGFR-mutant Non-small Cell Lung Cancer, Potentially Resectable

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04703322: A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

    Sponsor: Daiichi Sankyo Co., Ltd.. Phase: PHASE2. Conditions: Tenosynovial Giant Cell Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07597122: MIRNA QUANTIFICATION IN PATIENTS WITH SEPTIC SHOCK

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: . Conditions: Sepsis and Septic Shock

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06731322: Gut, Inflammation and Nutrition in Adult Patients After Fontan Operation

    Sponsor: University Medical Centre Ljubljana. Phase: . Conditions: Fontan Circulation, Fontan Procedure

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04188522: Imaging Post-Stroke Recovery: Using MEG to Evaluate Cognition

    Sponsor: Johns Hopkins University. Phase: . Conditions: Stroke, Stroke Sequelae, Stroke/Brain Attack

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06893731: Healthcare Utilization and Costs Among Hospitalized Patients With Cardiomyopathy

    Sponsor: China National Center for Cardiovascular Diseases. Phase: . Conditions: Cardiomyopathies, Cost

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04474431: Correlation of VEGF-A and Fluid Balance in Septic Shock

    Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Septic Shock

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06677931: Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Melasma

    Sponsor: Fujian Medical University Union Hospital. Phase: NA. Conditions: Melasma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06789731: Mindfulness-Based Interventions Targeting First-Generation College Student Retention in Rural Environments

    Sponsor: University of South Dakota. Phase: NA. Conditions: Depression, Anxiety

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03428802: Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

    Sponsor: Rutgers, The State University of New Jersey. Phase: PHASE2. Conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Neoplasm, Metastatic Malignant Solid Neoplasm, POLD1 Gene Mutation, POLE Gene Mutation, Recurrent Malignant Solid Neoplasm, Recurrent Ovarian Carcinoma, Stage III Breast Cancer AJCC v7, Stage III Ovarian Cancer AJCC v8, Stage IIIA Breast Cancer AJCC v7, Stage IIIA Ovarian Cancer AJCC v8, Stage IIIB Breast Cancer AJCC v7, Stage IIIB Ovarian Cancer AJCC v8, Stage IIIC Breast Cancer AJCC v7, Stage IIIC Ovarian Cancer AJCC v8, Stage IV Breast Cancer AJCC v6 and v7, Stage IV Ovarian Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03811002: Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

    Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06308653: Psilocybin for Major Depressive Disorder (MDD)

    Sponsor: Usona Institute. Phase: PHASE3. Conditions: Depressive Disorder, Major

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07217353: The Use of a Novel Vaginal Speculum for Endometrial Biopsies

    Sponsor: Rocky Vista University, LLC. Phase: NA. Conditions: Endometrial Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07366645: Clinical and Cost-Effectiveness of Silver Diamine Fluoride and Silver Fluoride, With or Without Application of LED, in Arresting Incipient Permament Molar Caries

    Sponsor: Cairo University. Phase: NA. Conditions: Incipient Caries

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05523245: Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI

    Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: . Conditions: Rectal Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07625072: Mental Rehearsal in Emergency Cricothyroidotomy Training

    Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Difficult Airway, Medical Training, Airway Management, Cricothyroidotomy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06060977: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

    Sponsor: Inmagene LLC. Phase: PHASE1. Conditions: Alopecia Areata (AA)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04027777: Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation

    Sponsor: Aktiia SA. Phase: NA. Conditions: Blood Pressure

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07299877: Perineural Dexamethasone, Dexmedetomidine, or Their Combination to Reduces Rebound Pain After Supraclavicular Brachial Plexus Block

    Sponsor: Al-Azhar University. Phase: PHASE4. Conditions: Brachial Plexus Blocks

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06138275: Elranatamab in R/R Multiple Myeloma

    Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07487857: Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy

    Sponsor: University of Castilla-La Mancha. Phase: NA. Conditions: Cerebral Palsy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07633457: Comparison Between Outcomes of Closure of Idiopathic Macular Hole Using Autologus Tenon Capsule Graft and Internal Limiting Membrane Flap Techniques (Pilot Study)

    Sponsor: Ain Shams University. Phase: NA. Conditions: Macular Hole Surgery, ILM Peeling, Tenon Capsule, ILM Flap, Macular Hole

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05753501: Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

    Sponsor: AbbVie. Phase: PHASE1. Conditions: Hematologic Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07372157: Neuromuscular Balance Exercise Effects in Overweight and Obese Individuals

    Sponsor: Marmara University. Phase: NA. Conditions: Overweight and Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06245057: Enriched Holistic Care to Eradicate Disparities in Maternal Morbidity

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: Morbidity;Perinatal

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07084857: Association Between Isokinetic Lower Extremity Muscle Strength and Bone Mineral Density in Elderly Women With and Without Osteoporosis

    Sponsor: Cairo University. Phase: . Conditions: Osteoporosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06497101: Effectiveness Trial of Temperament Based Therapy With Support (TBT-S)

    Sponsor: Oslo University Hospital. Phase: NA. Conditions: Anorexia Nervosa

    full page →ctgov ↗
    ← prev
    page 64 of 96
    next →